Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2003 Aug;13(4):267-71.
doi: 10.1016/s0924-977x(03)00032-4.

Omega-3 fatty acids in major depressive disorder. A preliminary double-blind, placebo-controlled trial

Affiliations
Clinical Trial

Omega-3 fatty acids in major depressive disorder. A preliminary double-blind, placebo-controlled trial

Kuan-Pin Su et al. Eur Neuropsychopharmacol. 2003 Aug.

Erratum in

  • Eur Neuropsychopharmacol. 2004 Mar;14(2):173

Abstract

Patients with depression have been extensively reported to be associated with the abnormality of omega-3 polyunsaturated fatty acids (PUFAs), including significantly low eicosapentaenoic acid and docosahexaenoic acid in cell tissue contents (red blood cell membrane, plasma, etc.) and dietary intake. However, more evidence is needed to support its relation. In this study, we conducted an 8-week, double-blind, placebo-controlled trial, comparing omega-3 PUFAs (6.6 g/day) [corrected] with placebo, on the top of the usual treatment, in 28 patients with major depressive disorder. Patients in the omega-3 PUFA group had a significantly decreased score on the 21-item Hamilton Rating Scale for Depression than those in the placebo group (P < 0.001). From the preliminary findings in this study, omega-3 PUFAs could improve the short-term course of illness and were well tolerated in patients with major depressive disorder.

PubMed Disclaimer

Similar articles

Cited by

Publication types

LinkOut - more resources